Join us on March 18, 2025, for the Optimizing the Diagnosis of ATTR-CM: Updates in Imaging and Best Practices webinar, led by Program Chair, Saurabh Malhotra, MD, MPH, FASNC.
This case-based program is designed to educate imaging physicians and technologists on the latest acquisition, interpretation, and reporting techniques of technetium-99m hydroxy methylene diphosphonate (Tc-99m HMDP) and technetium-99m pyrophosphate (Tc-99m PYP) and provide best practices for the use of each tracer.
Ongoing supply chain disruptions have made it challenging to rely on Tc-99m PYP for diagnosing transthyretin cardiomyopathy (ATTR-CM)—potentially delaying critical treatment for your patients. Tc-99m HMDP is a viable alternative, but how does it compare to Tc-99m PYP? Join this webinar to learn the key differences in acquisition, interpretation, and reporting.
Experts will guide you through:
✔ Best practices for using Tc-99m HMDP and Tc-99m PYP in ATTR-CM diagnosis.
✔ Key similarities and differences between Tc-99m PYP and Tc-99m HMDP.
✔ The importance of SPECT and SPECT/CT imaging in diagnosing ATTR-CM.
✔ Real-world case studies to enhance your clinical decision-making.
Registration Rates
Complimentary for ASNC Members!
$25 for Non-Members
A recording of the webinar will be made available for all registrants.
Credits
Physicians can earn 1 CME credit.
Learning Objectives
By the end of the program, you should be able to:
- Outline the similarities and differences between Tc-99m HMDP and Tc-99m PYP in acquiring, interpreting and reporting study results for ATTR-CM.
- Describe optimized cardiac amyloid radionuclide scintigraphy protocols to ensure accurate diagnosis with Tc-99m PYP and Tc-99m HMDP.
- Identify imaging characteristics that impact interpretation and diagnostic accuracy.
- Specify key components of an appropriate report to enhance diagnostic precision.
Agenda Overview
- Technetium-99m Labelled Cardiac Imaging Tracers
– Prem Soman, MD, PhD, MASNC - Evolving From Planar to SPECT: Why and What You Need to Do
– Wael Jaber, MD, FASNC - Clinical Cases
– Cigdem Akincioglu, MD, FASNC, and Saurabh Malhotra, MD, MPH, FASNC - Q&A
– Faculty - Closing Comments
– Saurabh Malhotra, MD, MPH, FASNC
Program Chair
Saurabh Malhotra, MD, MPH, FASNC
Faculty

Cigdem Akincioglu, MD, FASNC

Wael Jaber, MD, FASNC

Prem Soman, MD, PhD, MASNC
This program is supported by an unrestricted educational grant from Pfizer, Inc.
Event Format
Live Virtual Meeting
Event Category
Webinar
Credit Type
CME